Finance

Lists
Q3 2026 earnings • released • Revenue miss -0.46%
See results
PRN:TSE
Profound Medical Corp
CA$10.33
+1.87%
(+0.19) 1D
Nov 9, 4:00:00 PM GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for PRN...
Open
CA$10.17
High
CA$10.62
Low
CA$10.14
Mkt. cap
380.70M
Avg. vol.
16.66K
Volume
37.36K
52-wk high
CA$12.40
52-wk low
CA$6.52
EPS
-CA$1.40
Beta
0.63
Shares outstanding
36.63M
No. of employees
162
Open
CA$10.17
High
CA$10.62
Low
CA$10.14
Mkt. cap
380.70M
Avg. vol.
16.66K
Volume
37.36K
52-wk high
CA$12.40
52-wk low
CA$6.52
EPS
-CA$1.40
Beta
0.63
Shares outstanding
36.63M
No. of employees
162
News stories
From web sources and news partners
About Profound Medical Corp
CEO-
Employees162
Founded-
HeadquartersMississauga, Ontario, Canada
SectorHealth Care
IndustryMedical device
Last report
Nov 5, 2026
Fiscal period
Q3 2026
- / -
Revenue / Est. (CAD)
13.75M / 13.82M
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
5.98M
5.34M
2.48M
9.83M
Cost of goods sold
1.99M
1.50M
536.00K
2.15M
Cost of revenue
1.99M
1.50M
536.00K
2.15M
Research and development expenses
4.27M
5.26M
5.65M
5.81M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.09M
6.59M
7.36M
9.70M
Operating expense
11.36M
11.85M
13.01M
15.50M
Total operating expenses
13.35M
13.36M
13.55M
17.65M
Operating income
-7.37M
-8.02M
-11.07M
-7.82M
Other non operating income
-
-
-
196.00K
EBT including unusual items
-8.15M
-7.03M
-9.48M
-7.73M
EBT excluding unusual items
-8.15M
-7.03M
-9.48M
-7.73M
Income tax expense
26.00K
25.00K
55.00K
-4.00K
Effective tax rate
-0.32%
-0.36%
-0.58%
0.05%
Other operating expenses
-
-
-
-
Net income
-8.18M
-7.05M
-9.54M
-7.72M
Net profit margin
-136.77%
-132.15%
-384.21%
-78.56%
Earnings per share
-
-
-0.26
-0.21
Interest and investment income
160.00K
377.00K
336.00K
-
Interest expense
-
-
-
-
Net interest expenses
160.00K
377.00K
336.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.26M
-7.92M
-10.93M
-7.69M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps